Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
The research time span covered by the report is from 2019 to 2030; it provides an overview of the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market and also provides a deeper in-depth segmentation of the market by regions, product type and downstream industries.
The global Enzyme-Linked Immunosorbent Assay (ELISA) Tests market size in 2023 is 2350.0 million US dollars, and it is expected to be 3749.0 million US dollars by 2030, with a compound annual growth rate of 6.90% expected in 2024-2030.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Enzyme-Linked Immunosorbent Assay (ELISA) Tests market include Ortho Clinical Diagnostics (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Thermo Fisher Scientific (U.S.), Abbott (U.S.), and ZEUS Scientific, Inc (U.S.). The share of the top 3 players in the Enzyme-Linked Immunosorbent Assay (ELISA) Tests market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Enzyme-Linked Immunosorbent Assay (ELISA) Tests market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Direct accounted for XX% of Enzyme-Linked Immunosorbent Assay (ELISA) Tests market in 2023. Indirect share of XX%.
Vaccine Development accounted for XX% of the Enzyme-Linked Immunosorbent Assay (ELISA) Tests market in 2023. Immunology accounts for XX%.
For competitive landscape, prominent players with considerable market shares are comprehensively analyzed in this report. With information regarding the concentration ratio and detailed data reflecting the market performance of each player shared, the readers can acquire a holistic view of the competitive situation and a better understanding of their competitors.
As the COVID-19 takes over the world, we are continuously tracking the changes in the markets. We analyzed the impact of the pandemic in detail, along with other key factors, such as macro-economy, regional conflicts, industry related news and policies. Meanwhile, market investment scenario, technology status and developments, supply chain challenges, among other essential research elements are all covered.
Key Factors Considered:
COVID-19
The report describes the market scenario during and post the pandemic in the vision of upstream, major market participants, downstream major customers, etc. Other aspects, such as changes in consumer behavior, demand, transport capacity, trade flow under COVID-19, have also been taken into consideration during the process of the research.
Regional Conflict / Russia-Ukraine War
The report also presents the impact of regional conflict on this market in an effort to aid the readers to understand how the market has been adversely influenced and how it's going to evolve in the years to come.
Challenges & Opportunities
Factors that may help create opportunities and boost profits for market players, as well as challenges that may restrain or even pose a threat to the development of the players, are revealed in the report, which can shed a light on strategic decisions and implementation.
Chapter Outline
Chapter 1: Introduces the product overview, market scope, study objectives, and industry dynamic analysis, and then includes the global impact of the coronavirus disease (COVID-19).
Chapter 2: Analysis of the competitive environment of Enzyme-Linked Immunosorbent Assay (ELISA) Tests market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the players' M&A and expansion in recent years.
Chapters 3-6: Segmented the global Enzyme-Linked Immunosorbent Assay (ELISA) Tests market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapter 7: Analyzes the main companies in the Enzyme-Linked Immunosorbent Assay (ELISA) Tests industry, including their main businesses, products/services, sales, revenue, gross margin, and the latest developments.
Chapter 8: Analyzes the Enzyme-Linked Immunosorbent Assay (ELISA) Tests industry chain, including raw material analysis, sales and marketing, distributors and major downstream buyers.
Chapter 9: The main points and conclusions of the report.
Chapter 10: Concludes with an explanation of the data sources and research methods.
Highlights-Regions
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Argentina
Mexico
MEA
Saudi Arabia
UAE
Turkey
Player list
Ortho Clinical Diagnostics (U.S.)
F. Hoffmann-La Roche Ltd. (Switzerland)
Thermo Fisher Scientific (U.S.)
Abbott (U.S.)
ZEUS Scientific, Inc (U.S.)
B.D. (U.S.)
BioMérieux (France)
Enzo Life Sciences, Inc.(U.S.)
PerkinElmer, Inc. (U.S.)
Merck KGaA (Germany)
Bio-Rad Laboratories, Inc. (U.S.)
BioLegend, Inc (U.S.)
LOEWE Biochemica GmbH (Germany)
ELISA Technologies, Inc (U.S.).
R&D Systems, Inc.(U.S.)
Arbor Assays (U.S.)
Eurofins Scientific (Luxembourg)
Danaher (U.S.)
Sysmex Corporation (Japan)
Agilent Technologies, Inc. (U.S.)
Bruker (U.S.)
Siemens (U.S.)
General Electric (U.S.)
Types list
Direct
Indirect
Sandwich
Competitive
Application list
Vaccine Development
Immunology
Diagnostics
Toxicology
Drug Monitoring and Pharmaceutical Industry and Transplantation
Infectious Diseases
Cancer
Protein Quantitation
Others
The global Enzyme-Linked Immunosorbent Assay (ELISA) Tests market size in 2023 is 2350.0 million US dollars, and it is expected to be 3749.0 million US dollars by 2030, with a compound annual growth rate of 6.90% expected in 2024-2030.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Enzyme-Linked Immunosorbent Assay (ELISA) Tests market include Ortho Clinical Diagnostics (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Thermo Fisher Scientific (U.S.), Abbott (U.S.), and ZEUS Scientific, Inc (U.S.). The share of the top 3 players in the Enzyme-Linked Immunosorbent Assay (ELISA) Tests market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Enzyme-Linked Immunosorbent Assay (ELISA) Tests market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Direct accounted for XX% of Enzyme-Linked Immunosorbent Assay (ELISA) Tests market in 2023. Indirect share of XX%.
Vaccine Development accounted for XX% of the Enzyme-Linked Immunosorbent Assay (ELISA) Tests market in 2023. Immunology accounts for XX%.
For competitive landscape, prominent players with considerable market shares are comprehensively analyzed in this report. With information regarding the concentration ratio and detailed data reflecting the market performance of each player shared, the readers can acquire a holistic view of the competitive situation and a better understanding of their competitors.
As the COVID-19 takes over the world, we are continuously tracking the changes in the markets. We analyzed the impact of the pandemic in detail, along with other key factors, such as macro-economy, regional conflicts, industry related news and policies. Meanwhile, market investment scenario, technology status and developments, supply chain challenges, among other essential research elements are all covered.
Key Factors Considered:
COVID-19
The report describes the market scenario during and post the pandemic in the vision of upstream, major market participants, downstream major customers, etc. Other aspects, such as changes in consumer behavior, demand, transport capacity, trade flow under COVID-19, have also been taken into consideration during the process of the research.
Regional Conflict / Russia-Ukraine War
The report also presents the impact of regional conflict on this market in an effort to aid the readers to understand how the market has been adversely influenced and how it's going to evolve in the years to come.
Challenges & Opportunities
Factors that may help create opportunities and boost profits for market players, as well as challenges that may restrain or even pose a threat to the development of the players, are revealed in the report, which can shed a light on strategic decisions and implementation.
Chapter Outline
Chapter 1: Introduces the product overview, market scope, study objectives, and industry dynamic analysis, and then includes the global impact of the coronavirus disease (COVID-19).
Chapter 2: Analysis of the competitive environment of Enzyme-Linked Immunosorbent Assay (ELISA) Tests market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the players' M&A and expansion in recent years.
Chapters 3-6: Segmented the global Enzyme-Linked Immunosorbent Assay (ELISA) Tests market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapter 7: Analyzes the main companies in the Enzyme-Linked Immunosorbent Assay (ELISA) Tests industry, including their main businesses, products/services, sales, revenue, gross margin, and the latest developments.
Chapter 8: Analyzes the Enzyme-Linked Immunosorbent Assay (ELISA) Tests industry chain, including raw material analysis, sales and marketing, distributors and major downstream buyers.
Chapter 9: The main points and conclusions of the report.
Chapter 10: Concludes with an explanation of the data sources and research methods.
Highlights-Regions
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Argentina
Mexico
MEA
Saudi Arabia
UAE
Turkey
Player list
Ortho Clinical Diagnostics (U.S.)
F. Hoffmann-La Roche Ltd. (Switzerland)
Thermo Fisher Scientific (U.S.)
Abbott (U.S.)
ZEUS Scientific, Inc (U.S.)
B.D. (U.S.)
BioMérieux (France)
Enzo Life Sciences, Inc.(U.S.)
PerkinElmer, Inc. (U.S.)
Merck KGaA (Germany)
Bio-Rad Laboratories, Inc. (U.S.)
BioLegend, Inc (U.S.)
LOEWE Biochemica GmbH (Germany)
ELISA Technologies, Inc (U.S.).
R&D Systems, Inc.(U.S.)
Arbor Assays (U.S.)
Eurofins Scientific (Luxembourg)
Danaher (U.S.)
Sysmex Corporation (Japan)
Agilent Technologies, Inc. (U.S.)
Bruker (U.S.)
Siemens (U.S.)
General Electric (U.S.)
Types list
Direct
Indirect
Sandwich
Competitive
Application list
Vaccine Development
Immunology
Diagnostics
Toxicology
Drug Monitoring and Pharmaceutical Industry and Transplantation
Infectious Diseases
Cancer
Protein Quantitation
Others
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
